Dissemination trial results
SECONDARY
The results will be submitted to the German Clinical Trials Register (DRKS) and published in a peer reviewed journal. Furthermore, the patient group ILCO which was involved in defining the primary and secondary endpoints of the study will be used to disseminate the results among its members.